CD274 and neoplasm: Emerging radiotracers targeting melanin, fibroblast activation protein, PD-1 (programmed cell death protein 1)/PD-L1 (programmed cell death-ligand 1), and CD8+ T cells have demonstrated enhanced tumor specificity and are on their way to forming novel theranostic pairs.